Blood Cells Molecules and Diseases

Papers
(The H4-Index of Blood Cells Molecules and Diseases is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies32
Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update)29
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update)27
ABO blood groups, COVID-19 infection and mortality26
Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies?26
Effectiveness of convalescent plasma in Indian patients with COVID-1925
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis20
The potential role of emicizumab prophylaxis in severe von Willebrand disease19
Circ-PTK2 promotes the proliferation and suppressed the apoptosis of acute myeloid leukemia cells through targeting miR-330-5p/FOXM1 axis18
Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?16
MicroRNA expression patterns in HbE/β-thalassemia patients: The passwords to unlock fetal hemoglobin expression in β-hemoglobinopathies15
Acquired von Willebrand syndrome in ECMO patients: A 3-year cohort study15
Potential causal role of l-glutamine in sickle cell disease painful crises: A Mendelian randomization analysis14
Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model13
Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients13
0.13491988182068